News | April 07, 2014

New method could provide an alternative to "watch and wait" or surgery


April 7, 2014 — A new multicenter clinical trial seeks to offer men another option for treating prostate cancer, one that physicians hope will treat cancers with fewer side effects.

As part of that trial, City of Hope in Duarte, Calif., has become the first center in the nation to perform a new procedure using a focused beam of ultrasound energy to “ablate” the prostate cancer. Traditional treatment approaches, such as surgery and radiation, are potentially very effective in treating prostate cancer, but some men are left facing incontinence or impotence. Men with very slow-growing cancers may choose a “watch and wait” approach, monitoring the cancer and determining appropriate interventions if they become necessary.

In this ultrasound ablation technique, the ultrasound is guided by MRI (magnetic resonance imaging) technology, allowing the ultrasound to be delivered very precisely to the site of the cancer. The imaging provides real-time thermal feedback, which helps physicians determine at the time of the procedure if enough ultrasound was delivered to the targeted area.

“The potential is that if we could provide a focal therapy that has a much lower risk profile compared to standard therapies, this may potentially be an option for men who choose not to ‘watch and wait,’” said Jeffrey Wong, M.D., chair of radiation oncology at City of Hope and a primary investigator on the trial. “At this time, the treatment is under trial and still being evaluated.”

The technology is approved by the U.S. Food and Drug Administration (FDA) to treat painful bone metastases, and has been used in other countries to treat prostate cancer.

Jaime Negrette, who lives in Long Beach, was diagnosed with prostate cancer by a PSA (prostate-specific antigen) test and sought out an alternative treatment to surgery or radiation. He was treated in mid-November 2013. About six months after treatment, Negrette will know more definitively if the treatment was a success, but so far, he has had no side effects and is doing well.

“I’ve had friends who have been treated for prostate cancer,” he said. “Some men have issues that last long after their prostate was removed, so I was very happy to have another choice.”

The trial includes men with low-risk prostate cancer, with no more than two areas in the prostate gland involved with cancer. The multicenter feasibility trial is ongoing.

For more information: www.cityofhope.org


Related Content

Feature | Magnetic Resonance Imaging (MRI) | Robert L. Bard, MD, and Lennard M. Gettz, EdD

Since the advent of the magnetic resonance imaging (MRI) exam on human patients in the late 1970s, this innovation ...

Time September 25, 2023
arrow
News | Prostate Cancer

September 22, 2023 — According to an accepted manuscript published in the American Journal of Roentgenology (AJR) ...

Time September 22, 2023
arrow
News | Contrast Media

September 21, 2023 — Imaging Biometrics, LLC announced the results of a study that validates IB Neuro’s processing of ...

Time September 21, 2023
arrow
Sponsored Content | Case Study | Radiology Imaging | By Tim Hodson

In June, the Philips Radiology Experience Tour hit the road to provide healthcare professionals with an opportunity to ...

Time September 19, 2023
arrow
Feature | Magnetic Resonance Imaging (MRI) | By Christine Book

The world of medical imaging is marking a significant milestone in 2023: the 50th anniversary of magnetic resonance ...

Time September 19, 2023
arrow
News | Radiation Oncology

September 13, 2023 — Intensity-modulated radiation therapy (IMRT) should be the preferred choice when treating patients ...

Time September 13, 2023
arrow
News | Radiation Oncology

September 12, 2023 — Michael J. Zelefsky, MD, a renowned leader in radiation oncology, is joining NYU Langone’s ...

Time September 12, 2023
arrow
News | Lung Imaging

September 11, 2023 — Polarean Imaging plc (AIM: POLX), a commercial-stage medical device leader in advanced magnetic ...

Time September 11, 2023
arrow
Feature | PET Imaging

According to a new report from Transparency Market Research (TMR), PET radiotracers are expected to rise at a CAGR of 8 ...

Time September 05, 2023
arrow
News | Radiology Imaging

August 24, 2023 — Medical imaging via X-rays, CT scans, MRIs and ultrasounds provide health-care professionals with ...

Time August 24, 2023
arrow
Subscribe Now